DUBLIN--(BUSINESS WIRE)--"A Practical Overview of Pre-Filled Syringes Training Course (Nov 5th - Nov 6th, 2025)" training has been added to ResearchAndMarkets.com's offering. This course offers a ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment via a ...

Genentech announced that the Food and Drug Administration (FDA) has approved Lucentis (ranibizumab injection) 0.5mg pre-filled syringe (PFS) as a new method of administration to treat both wet ...

Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...

(MENAFN- GlobeNewsWire - Nasdaq) This course offers market opportunities through comprehensive training on pre-filled syringe processing, featuring independent, vendor-neutral expertise and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...

(Thomson Reuters ONE via COMTEX) -- Novartis International AG / Novartis introduces Lucentis(R) in state of the art pre-filled syringe . Processed and transmitted by NASDAQ OMX Corporate Solutions.